The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace
Abstract
Nitric oxide (NO·) is an important protective molecule in the vasculature, and endothelial NO· synthase (eNOS) is responsible for most of the vascular NO· produced. A functional eNOS oxidizes its substrate l -arginine to l -citrulline and NO·. This normal function of eNOS requires dimerization of the enzyme, the presence of the substrate l -arginine, and the essential cofactor (6 R )-5,6,7,8-tetrahydro- l -biopterin (BH 4 ), one of the most potent naturally occurring reducing agents. Cardiovascular risk factors such as hypertension, hypercholesterolemia, diabetes mellitus, or chronic smoking stimulate the production of reactive oxygen species in the vascular wall. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases represent major sources of this reactive oxygen species and have been found upregulated and activated in animal models of hypertension, diabetes, and sedentary lifestyle and in patients with cardiovascular risk factors. Superoxide (O 2 · − ) reacts avidly with vascular NO· to form peroxynitrite (ONOO − ). The cofactor BH 4 is highly sensitive to oxidation by ONOO − . Diminished levels of BH 4 promote O 2 · − production by eNOS (referred to as eNOS uncoupling). This transformation of eNOS from a protective enzyme to a contributor to oxidative stress has been observed in several in vitro models, in animal models of cardiovascular diseases, and in patients with cardiovascular risk factors. In many cases, supplementation with BH 4 has been shown to correct eNOS dysfunction in animal models and patients. In addition, folic acid and infusions of vitamin C are able to restore eNOS functionality, most probably by enhancing BH 4 levels as well.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The uncoupling causes eNOS activity to change from healthy (producing NO) to toxic (generating superoxide) (303).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [303]
In the citing paper
“Similarly, vascular disease, cardiovascular disease (CVD), and metabolic syndrome all share effective loss of NO function[23,35–39].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [23]
Citations
Cites
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Rajagopalan, S., Kurz, S. D., Münzel, T. F., Tarpey, M. M., Freeman, B. Α., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,466
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961
Hypercholesterolemia increases endothelial superoxide anion production.
Ohara, Y., Peterson, T. E., & Harrison, D. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116491 · Cited by 1,765
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Landmesser, U., Dikalov, S., Price, S. R., McCann, L. A., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14172 · Cited by 1,652
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M. P., Thaiss, F., Stahl, R. A. K., Warnholtz, A., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.2.e14 · Cited by 1,190
Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.
Förstermann, U., Closs, E. I., Pollock, J. S., Nakane, M., Schwarz, P., Gath, I., & Kleinert, H. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.1121 · Cited by 1,110
Pollock, J. S., Förstermann, U., Mitchell, J. A., Warner, T. D., Schmidt, H. H. H. W., Nakane, M., & Murad, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10480 · Cited by 979
Ting, H. H., Timimi, F. K., Boles, K., Creager, S. J., Ganz, P., & Creager, M. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118394 · Cited by 869
Flagged first, then by citations
Research works printed but not linked: 23
- 10.1161/res.86.3.347 · DOI
- Li H Witte K August M Brausch I Gödtel-Armbrust U Habermeier A Closs EI Oelze M Münzel T Förstermann U. Reversal of eNOS uncoupling and upregulation of eNOS expression lowers blood pressure in hypertensive rats. J Am Coll Cardiol. In press.
- 10.1161/res.88.2.e14 · DOI
- 10.1161/circ.99.15.2027 · DOI
- 10.1161/res.86.5.494 · DOI
- 10.1161/circ.94.11.2756 · DOI
- 10.1161/circ.101.11.1261 · DOI
- 10.1161/circ.100.21.2131 · DOI
- 10.1161/hyp.30.1.57 · DOI
- 10.1161/res.77.3.510 · DOI
- 10.1161/circ.103.9.1282 · DOI
- 10.1161/hyp.33.6.1353 · DOI
- 10.1161/res.86.1.e7 · DOI
- 10.1161/res.86.2.e36 · DOI
- 10.1161/circ.104.10.1119 · DOI
- 10.1161/res.87.2.99 · DOI
- 10.1161/res.87.7.566 · DOI
- 10.1161/hyp.38.5.1044 · DOI
- 10.1161/circ.104.22.2673 · DOI
- 10.1161/circ.94.1.6 · DOI
- 10.1161/circ.97.3.237 · DOI
- 10.1161/atvb.22.1.6 · DOI
- 10.1161/atvb.20.1.185 · DOI
Cited by
Sorted by citations
Items 901–1,000 of 1,003
Logesh, R., Radhakrishnan, A., Alagarsamy, K. N., Srivastava, A., Dhingra, S., Booker, A., Rolfe, V., Palaniswamy, D. S., & Mohankumar, S. K. (2022) · PharmaNutrition · doi:10.1016/j.phanu.2022.100296 · Cited by 24
Villalobos-Labra, R., Liu, R., Spaans, F., Sáez, T., Quon, A., Wong, M. E., Pink, D., Lewis, J. D., Vatish, M., Davidge, S. T., et al. (2022) · Bioscience Reports · doi:10.1042/bsr20222185 · Cited by 22
Cao, Y., Mu, J., Fang, Y., Yuan, Z., & Liu, F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14048062 · Cited by 24
Schuchardt, M., Prüfer, J., Prüfer, N., Wiedon, A., Huang, T., Chebli, M., Jankowski, V., Jankowski, J., Schäfer‐Korting, M., Zidek, W., et al. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0750-6 · Cited by 24
“NO is interpreted as an endotheliumderived relaxing factor [1].”
BackgroundJaveshghani, D., Schiffrin, E. L., Sairam, M. R., & Touyz, R. M. (2009) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2009.07.002 · Cited by 24
Ritchie, R. H., Leo, C. H., Qin, C. X., Stephenson, E. J., Bowden, M. A., Buxton, K. D., Lessard, S. J., Rivas, D. A., Koch, L. G., Britton, S. L., et al. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00638.2012 · Cited by 24
Tetrahydrobiopterin: A Vascular Redox Target to Improve Endothelial Function
Channon, K. M. (2012) · Current Vascular Pharmacology · doi:10.2174/157016112803520819 · Cited by 24
Ke, J., Wei, R., Yu, F., Zhang, J., & Hong, T. (2016) · Peptides · doi:10.1016/j.peptides.2016.10.009 · Cited by 24
Fontana, J., Zima, M., & Větvička, V. (2018) · Immunological Investigations · doi:10.1080/08820139.2018.1523925 · Cited by 24
“Uncoupling of endothelial NOS (eNOS) in both myocardium and vasculature resulting in conversion of nitric oxide (NO) production to generation of O2 − can contribute to heart failure development (Forstermann and Munzel, 2006).”
BackgroundScarcello, E., Lobysheva, I. I., Bouzin, C., Jacques, P., Lison, D., & Dessy, C. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.110938 · Cited by 24
Role of nitric oxide synthase isoforms for ophthalmic artery reactivity in mice
Laspas, P., Goloborodko, E., Sniatecki, J. J., Kordasz, M., Manicam, C., Wojnowski, L., Li, H., Patzak, A. R., Pfeiffer, N., & Gericke, A. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.06.018 · Cited by 24
Soluble guanylyl cyclase during postnatal porcine pulmonary maturation
Moreno, L., González-Luis, G. E., Cogolludo, A. L., Lodi, F., López-Farré, A. J., Tamargo, J. L., Villamor, E., & Pérez‐Vizcaíno, F. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00244.2004 · Cited by 24
Pharmacological Interventions to Prevent Vascular Endothelial Dysfunction: Future Directions
Balakumar, P., Koladiya, R. U., Ramasamy, S., Rathinavel, A., & Singh, M. (2008) · Eisei kagaku · doi:10.1248/jhs.54.1 · Cited by 24
Amelioration of Endothelial Dysfunction in Diabetes: Role of Takeda G Protein–Coupled Receptor 5
Cai, Z., Yuan, S., Zhong, Y., Deng, L., Li, J., Tan, X., & Feng, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.637051 · Cited by 23
Feng, Y., Huang, Z., Ma, X., Zong, X., Tešić, V., Ding, B., Wu, C. Y., Lee, R. H., & Zhang, Q. (2024) · Antioxidants · doi:10.3390/antiox13060633 · Cited by 23
“Our study suggests a new therapeutic approach to alleviate endothelial dysfunction caused Our study suggests a new therapeutic approach to alleviate endothelial dysfunction caused by cerebrovascular disease. by cerebrovascular disease.”
BackgroundPacanowski, M. A., Zineh, I., Cooper‐DeHoff, R. M., Pepine, C. J., & Johnson, J. A. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.81 · Cited by 23
Regulation of endothelial nitric oxide synthase activation in endothelial cells by S1P1 and S1P3
Tölle, M., Klöckl, L., Wiedon, A., Zidek, W., van der Giet, M., & Schuchardt, M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.009 · Cited by 23
“Here, nitric oxide (NO) generated by the endothelial NO synthase (eNOS) plays a major role [2].”
BackgroundThe Antioxidant Role of One-Carbon Metabolism on Stroke
Burgess, K., Bennett, C., Mosnier, H., Kwatra, N., Bethel, F. B., & Jadavji, N. M. (2020) · Antioxidants · doi:10.3390/antiox9111141 · Cited by 23
Role of Rho in Salt-Sensitive Hypertension
Kawarazaki, W., & Fujita, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062958 · Cited by 23
“Reductions in the expression or activity of eNOS, and its uncoupling, which enhances oxidative stress by decreasing NO and increasing O2 and peroxynitrite production, have a crucial role in the process of endothelial dysfunction [150].”
BackgroundSarmah, N., Nauli, A. M., Ally, A., & Nauli, S. M. (2022) · Molecules · doi:10.3390/molecules27092835 · Cited by 23
“Endothelial NOS maintains a healthy CV system (CVS), partly by regulating and maintaining vascular tone: migration, production, and maturation of cells; leukocyte adhesion; and platelet aggregation [4].”
BackgroundInfluentialWang, S., Yao, W., Zhu, X., Wang, J., Lu, L., Zhu, N., Lan, T., Kuang, Y., Zhu, W., Liu, R., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115701 · Cited by 23
The time is now: regular exercise maintains vascular health in ageing women
Tamariz‐Ellemann, A., Wickham, K. A., Nørregaard, L. B., Gliemann, L., & Hellsten, Y. (2022) · The Journal of Physiology · doi:10.1113/jp282896 · Cited by 23
“For example, GPER activation can turn on signalling cascades that promote eNOS activation (Fredette et al. 2018).”
BackgroundKim, B., Lee, K., Chinannai, K. S., Ham, I., Bu, Y., Kim, H., & Choi, H. (2015) · Molecules · doi:10.3390/molecules200610721 · Cited by 23
“In the vascular smooth cells, NO gas activates soluble guanylate cyclase (sGC), which increases cyclic GMP (cGMP) and leads to cGMP-mediated vasodilation [19–21].”
BackgroundAlfuzosin attenuates erectile dysfunction in rats with partial bladder outlet obstruction
Gür, S., Sikka, S. C., Chandra, S., Koka, P. S., Agrawal, K. C., Kadowitz, P. J., & Hellstrom, W. J. G. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07914.x · Cited by 23
Nitrative Stress Participates in Endothelial Progenitor Cell Injury in Hyperhomocysteinemia
Dong, Y. H., Sun, Q., Liu, T., Wang, H., Jiao, K., Xu, J., Liu, X., Liu, H., & Wang, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158672 · Cited by 23
Rationale for nebivolol/valsartan combination for hypertension
Giles, T. D., Cockcroft, J. R., Pitt, B., Jakate, A. S., & Wright, H. M. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001412 · Cited by 23
“NO, a metastable free radical, is a key mediator of endothelial vasodilation, renal fluid retention, and platelet aggregation/adhesion [26].”
Ochoa‐Martínez, Á. C., Ruíz-Vera, T., Almendarez‐Reyna, C. I., Orta-Garcia, S. T., & Pérez‐Maldonado, I. N. (2017) · Chemosphere · doi:10.1016/j.chemosphere.2017.08.055 · Cited by 23
Lataro, R. M., Silva, M. A. B., Mestriner, F., Cáu, S. B. D. A., Tostes, R. C., & Salgado, H. C. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz036 · Cited by 23
Lee, Y. S., Kim, H., Kim, J., Seol, G. H., & Lee, K. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2516-6 · Cited by 23
Shrestha, A. K., Menon, R., El‐Saie, A., Barrios, R. J., Reynolds, C. L., & Shivanna, B. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00013.2020 · Cited by 25
eNOS Tag SNP Haplotypes in Hypertensive Disorders of Pregnancy
Muniz, L. G., Luizon, M. R., Palei, A. C., Lacchini, R., Duarte, G. G., Cavalli, R. D. C., Tanus-Santos, J. E., & Sandrim, V. C. (2012) · DNA and Cell Biology · doi:10.1089/dna.2012.1768 · Cited by 23
Kataoka, K., Tokutomi, Y., Yamamoto, E., Nakamura, T., Fukuda, M., Dong, Y., Ichijo, H., Ogawa, H., & Kim‐Mitsuyama, S. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833fc8b0 · Cited by 23
Aschauer, S., Gouya, G., Klickovic, U., Storka, A., Weisshaar, S., Vollbracht, C., Krick, B., Weiss, G., & Wolzt, M. (2014) · Vascular Pharmacology · doi:10.1016/j.vph.2014.01.007 · Cited by 23
A Close Look at the Endothelium: Its Role in the Regulation of Vasomotor Tone
Mas, M. (2008) · European Urology Supplements · doi:10.1016/j.eursup.2008.10.011 · Cited by 23
Therapeutics Targeting of Dysregulated Redox Equilibrium and Endothelial Dysfunction
Risbano, M. G., & Gladwin, M. T. (2013) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-45805-1_13 · Cited by 32
Li, J., Zhang, J., Yu, P., Xu, H., Wang, M., Chen, Z., Yu, B., Gao, J., Jin, Q., Jia, F., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.03.010 · Cited by 22
“Produced by enzyme-catalyzed oxidation of arginine, NO is critical in preventing platelet aggregation, regulating smooth muscle cells ’ phenotype and maintaining endothelial cells ’ functions [15 – 18].”
MethodIsorhamnetin: what is the in vitro evidence for its antitumor potential and beyond?
Lei, J., Yang, J., Bao, C., Lu, F., Wu, Q., Wu, Z., Lv, H., Zhou, Y., Liu, Y., Zhu, N., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1309178 · Cited by 22
Endothelial Reactive Oxygen Species: Key Players in Cardiovascular Health and Disease
Craige, S. M., Kaur, G., Bond, J. M., Caliz, A. D., Kant, S., & Keaney, J. F. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0706 · Cited by 24
Acid‐Triggered Dual‐Functional Hydrogel Platform for Enhanced Bone Regeneration
Xiao, Y., Ma, J., Yuan, X., Wang, H., Ma, F., Wu, J., Chen, Q., Hu, J., Wang, L., Zhang, Z., et al. (2025) · Advanced Science · doi:10.1002/advs.202415772 · Cited by 22
Dias, F. M. V., Ribeiro, E. H., Fernandes, A. A., Fiorim, J., Travaglia, T. C. F., Vassallo, D. V., & Stefanon, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106345 · Cited by 22
Vecchione, C., Villa, F., Carrizzo, A., Spinelli, C., Damato, A., Ambrosio, M., Ferrario, A., Madonna, M., Uccellatore, A., Lupini, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10341-x · Cited by 22
Ward, N. C., Chen, K., Li, C., Croft, K. D., & Keaney, J. F. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05509.x · Cited by 22
“Endothelial dysfunction is frequently associated with several cardiovascular disease risk factors.(3) The precise mechanisms behind endothelial dysfunction are largely unknown, although a number of factors are thought to be involved, including a reduction in NO bioavailability and bioactivity via reaction with superox…”
BackgroundGonzález-Torres, L., Vázquez‐Velasco, M., Olivero-David, R., Bastida, S., Benedı́, J., González, R. R., González‐Muñoz, M. J., & Sánchez-Muniz, F. J. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0441-9 · Cited by 22
“[15], demanding antioxidants to block those”
Bollmann, F., Wu, Z., Oelze, M. W., Siuda, D., Xia, N., Henke, J., Daiber, A., Li, H., Stumpo, D. J., Blackshear, P. J., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.566984 · Cited by 22
“Furthermore, RONS can enhance oxidative stress by the inhibition of superoxide dismutases (14) and uncoupling of NO synthases (15).”
BackgroundPlatelet Redox Balance in Diabetic Patients With Hypertension Improved by n-3 Fatty Acids
McDonald, D., O’Kane, F., McConville, M., Devine, A. B., & McVeigh, G. E. (2012) · Diabetes Care · doi:10.2337/dc12-0304 · Cited by 21
AN OVERVIEW ON SICKLE CELL DISEASE PROFILE
Kaur, M., Dangi, C. B. S., & Singh, M. (2013) · Cited by 22
Shi, F., Zhao, T., Wang, Y., Cao, X., Yang, C., Gao, Y., Li, C., Zhao, J., Zhang, S., & Sun, X. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000438646 · Cited by 22
Metabolic Syndrome, Redox State, and the Proteasomal System
Höhn, A., König, J., & Jung, T. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6815 · Cited by 23
“…radical production (18) while triggering the formation of MCP-1 and cell adhesion molecules (ICAM-1 and VCAM-1) in endothelial cells—the availability of c NO depends on endothelial nitric oxide synthase (eNOS) activity, and a diminished eNOS activity is associated with essential hypertension (13).”
High salt diet impairs cerebral blood flow regulation via salt‐induced angiotensin II suppression
Allen, L. A., Schmidt, J. R., Thompson, C. T., Carlson, B. E., Beard, D. A., & Lombard, J. H. (2018) · Microcirculation · doi:10.1111/micc.12518 · Cited by 21
Marjoram Relaxes Rat Thoracic Aorta Via a PI3-K/eNOS/cGMP Pathway
Badran, A., Baydoun, E., Samaha, A., Pintus, G., Mesmar, J. E., Iratni, R., Issa, K., & Eid, A. H. (2019) · Biomolecules · doi:10.3390/biom9060227 · Cited by 23
Alamu, O. A., Rado, M., Ekpo, O. E., & Fisher, D. (2020) · Cells · doi:10.3390/cells9020403 · Cited by 22
“Other important enzymatic antioxidants such as glutathione peroxidase (GPx), and catalase (CAT), help to neutralize H2O2 to water and oxygen [11] Endothelial nitric oxide synthase (eNOS) is another enzyme which normally plays a protective role in the vascular endothelial cell through its production of nitric oxide (NO…”
BackgroundDaiber, A., Oelze, M. W., Daub, S., Steven, S., Schuff, A., Kröller‐Schön, S., Hausding, M., Wenzel, P., Schulz, E., Gori, T., et al. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_48 · Cited by 21
Cytoglobin as a Biomarker in Cancer: Potential Perspective for Diagnosis and Management
Bholah, T. C., Neergheen, V. S., Hodges, N. J., Dyall, S. D., & Bahorun, T. (2015) · BioMed Research International · doi:10.1155/2015/824514 · Cited by 22
“NO is a known endogenous molecule which has an important regulatory role in the dilation of blood vessels [42].”
BackgroundEgemnazarov, B., Sydykov, A. S., SCHERMULY, R. T., Weißmann, N., Stasch, J., Шогаибович, С. А., Seeger, W., Grimminger, F., & Ghofrani, H. A. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90377.2008 · Cited by 22
Lu, Y., Han, F., Shioda, N., Moriguchi, S., Shirasaki, Y., Qin, Z.-H., & Fukunaga, K. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050716 · Cited by 22
“Thus, eNOS uncoupling accompanied by BH4 depletion is believed to be crucial for heart damage after cardiovascular disorders, including hypertension (Förstermann and Münzel, 2006), atherosclerosis (Lahera et al., 2007), and diabetes (Thum et al., 2007).”
BackgroundThe Potential Role of Kallistatin in the Development of Abdominal Aortic Aneurysm
Li, J., Krishna, S. M., & Golledge, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081312 · Cited by 22
Zhan, J., Wei, J., Liu, Y., Wang, P.-X., & Zhu, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.139548 · Cited by 24
Biochemical changes of the endothelium in the murine model of NO-deficient hypertension
Pacia, M. Z., Mateuszuk, Ł., Chłopicki, S., Barańśka, M., & Kaczor, A. (2014) · The Analyst · doi:10.1039/c4an01870b · Cited by 21
Marks, E. D., & Kumar, A. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.04.010 · Cited by 21
Weisrock, F., Fritschka, M., Beckmann, S. B., Litmeier, S., Wagner, J., Tahirović, E., Radenovic, S., Zelenak, C., Hashemi, D., Busjahn, A., et al. (2017) · Vascular Medicine · doi:10.1177/1358863x17706752 · Cited by 21
Chen, Y., Guo, M., Liu, R.-Y., Ma, L. Q., & Cui, X. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.126653 · Cited by 21
Redox Switches in Noise-Induced Cardiovascular and Neuronal Dysregulation
Frenis, K., Kuntić, M., Hahad, O., Jiménez, M. T. B., Oelze, M. W., Daub, S., Steven, S., Münzel, T. F., & Daiber, A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.784910 · Cited by 22
Rampin, A., Carrabba, M., Mutoli, M., Eman, C. L., Testa, G., Madeddu, P. R., & Spinetti, G. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0134 · Cited by 24
“Monomeric eNOS is unable to synthesize NO, and synthesizes O 2 - instead, exacerbating oxidative stress (47).”
The Safety of Long-Term Proton Pump Inhibitor Use on Cardiovascular Health: A Meta-Analysis
Jeridi, D., Pellat, A., Ginestet, C., Assaf, A., Hallit, R., Corre, F., & Coriat, R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144096 · Cited by 21
“Endothelial nitric oxide synthase (NOS) is an enzyme that produces the vasoprotective and vasodilator molecule nitric oxide (NO) [43].”
BackgroundEndothelial cell-specific loss of eNOS differentially affects endothelial function
Bu, S., Nguyen, H. C., Nikfarjam, S., Michels, D., Rasheed, B., Maheshkumar, S., Singh, S., & Singh, K. K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274487 · Cited by 21
“ENOS, is expressed mainly in endothelium of the large arteries and impaired eNOS expression is implicated in development and progression of cardiovascular diseases [9].”
BackgroundVillalobos-Labra, R., Liu, R., Spaans, F., Sáez, T., Semería-Maitret, T., Quon, A., Sawamura, T., Cooke, C. M., & Davidge, S. T. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21205 · Cited by 21
Tsuge, M., Uda, K., Eitoku, T., Matsumoto, N., Yorifuji, T., & Tsukahara, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015450 · Cited by 21
The Role of Stem Cells as Therapeutics for Ischaemic Stroke
Ya, J., Pellumbaj, J., Hashmat, A., & Bayraktutan, U. (2024) · Cells · doi:10.3390/cells13020112 · Cited by 22
Jin, K., & Vaziri, N. D. (2013) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0851-3 · Cited by 21
Endothelial nitric oxide synthase limits the inflammatory response in mouse cutaneous leishmaniasis
Fritzsche, C., Schleicher, U., & Bogdan, C. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.05.022 · Cited by 21
Paradoxical Association of C-Reactive Protein with Endothelial Function in Rheumatoid Arthritis
Holmes, M. V., Jiang, B., McNeill, K. L., Wong, M., Oakley, S. P., Kirkham, B. W., & Chowienczyk, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010242 · Cited by 22
“In the presence of Reactive Oxygen Species, NO can be deleterious to the endothelium[38], yet FMD measures the vasodilatory (protective) function of EDNO in response to shear stress of the vessel wall[28].”
BackgroundPapatheodorou, S., Buettner, H., Rice, M. B., & Mittleman, M. A. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.12.033 · Cited by 21
Isolation and Culture of Endothelial Cells from Large Vessels
Montezano, A. C. I., Neves, K. B., Alves-Lopes, R., & Rios, F. J. O. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6625-7_26 · Cited by 21
mTORc1 activity is necessary and sufficient for phosphorylation of eNOSS1177
Decker‐Rockefeller, B., & Pumiglia, K. M. (2018) · Physiological Reports · doi:10.14814/phy2.13733 · Cited by 20
cGMP Signaling in Cardiovascular Diseases: Linking Genotype and Phenotype
Dang, T. A., Schunkert, H., & Kessler, T. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000744 · Cited by 22
Endothelial Function in Patients With Continuous-Flow Left Ventricular Assist Devices
Poredoš, P., Jezovnik, M. K., Radovancevic, R., & Gregorič, I. D. (2020) · Angiology · doi:10.1177/0003319720946977 · Cited by 21
“Characteristics of blood flow and accompanying shear stress represent a key activator of NO synthesis.(4) A vasodilator and vasoconstrictor imbalance incapacitates the vasodilatory response, which is the most recognized indicator of endothelial dysfunction (ED).”
BackgroundBahls, M., Friedrich, N., Atzler, D., Felix, S. B., Nauck, M. A., Böger, R. H., Völzke, H., Schwedhelm, E., & Dörr, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131293 · Cited by 21
The importance of sphingolipids and reactive oxygen species in cardiovascular development
Poloni, J. D. F., Chapola, H., Feltes, B. C., & Bonatto, D. (2014) · Biology of the Cell · doi:10.1111/boc.201400008 · Cited by 21
“However, NADPH oxidases-derived O2 reacts with NO, favouring the formation of ONOO− in endothelial cells and limiting NO bioavailability (Figure 3; Cai et al., 2003; Förstermann and Münzel, 2006; Brandes et al., 2010).”
BackgroundInfluentialLi, L., Luo, Y.-M., Liu, J., Zhang, Y., Fu, X., & Yang, D. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/7915415 · Cited by 21
“eNOS through the conversion of L-arginine (L-arg) into L-citrulline in vascular endothelial cells, and NO in turn activates sGC; the latter promotes conversion of guanosine triphosphate (GTP) to cGMP [11].”
BackgroundThe Role of Oxidative Stress in Endothelial Dysfunction and Vascular Inflammation
Osto, E., & Cosentino, F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-373866-0.00022-8 · Cited by 23
Thelma, B. K., Tiwari, A. K., Deshpande, S. N., Lerer, B., & Nimgaonkar, V. L. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.12.019 · Cited by 21
Cell‐To‐Cell Communication in the Resistance Vasculature
King, D. R., Sedovy, M. W., Eaton, X., Dunaway, L. S., Good, M. E., Isakson, B. E., & Johnstone, S. R. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210040 · Cited by 32
Sonowal, H., Pal, P. B., Shukla, K., & Ramana, K. V. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2769347 · Cited by 19
“Several studies have shown that decreased eNOS levels could lead to endothelial dysfunction [26, 63, 64].”
BackgroundNO Signaling in the Cardiovascular System and Exercise
Fernandes, T. M., Gomes‐Gatto, C. D. V., Pereira, N. P., Alayafi, Y. R., das Neves, V. J., & de Oliveira, E. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4304-8_13 · Cited by 22
Qiao, M.-M., Liu, F., Liu, Y., Guo, L., Zhou, Q., Peng, C. Y., & Xiong, L. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103275 · Cited by 20
Antioxidant metal oxide nanozymes: role in cellular redox homeostasis and therapeutics
Singh, N. (2020) · Pure and Applied Chemistry · doi:10.1515/pac-2020-0802 · Cited by 20
Yang, H.-Y., Hu, L., Chen, H.-J., Chen, R.-Y., Hu, C.-K., & Shen, C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912331 · Cited by 20
“The endothelium modulates vascular tone mainly through the synthesis of nitric oxide (NO) by the endothelial NO synthase isoform [17,18].”
BackgroundMechanisms and Cardiorenal Complications of Chronic Anemia in People with HIV
Kamvuma, K. M., Hamooya, B. M., Munsaka, S. M., Masenga, S. K., & Kirabo, A. (2024) · Viruses · doi:10.3390/v16040542 · Cited by 24
Attachaipanich, T., Chattipakorn, S. C., & Chattipakorn, N. (2024) · Acta Physiologica · doi:10.1111/apha.14199 · Cited by 22
“86,87 The eNOS has several phosphorylation sites including serine (Ser) and threonine (Thr) residues.”
Functional Deterioration of Endothelial Nitric Oxide Synthase after Focal Cerebral Ischemia
Yagita, Y., Kitagawa, K., Oyama, N., Yukami, T., Watanabe, A., Sasaki, T., & Mochizuki, H. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.112 · Cited by 20
Shin, W., Cuong, T. D., Lee, J. H., Min, B., Jeon, B. H., Lim, H. K., & Ryoo, S. (2011) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2011.15.3.123 · Cited by 20
“This normal function of endothelial NOS (eNOS) requires dimerization of the enzyme, the substrate L-arginine, and the essential cofactor (6R)-5,6,7,8-tetrahydroL-biopterin (BH4) [25].”
BackgroundNi, R., Peleg, T., & Gross, P. L. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300090 · Cited by 20
“In patients with cardiovascular risk factors, eNOS can be uncoupled.(37) Uncoupling refers to the state where eNOS products combine with products of nicotinamide adenine dinucleotide phosphate-oxidases to form peroxynitrite, which oxidizes (6R)-5,6,7,8-tetrahydro-L-biopterin, an essential eNOS cofactor.”
BackgroundThe Endothelium, Part II: EDHF-Mediated Responses "The Classical Pathway"
Félétou, M. (2011) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00032ed1v01y201105isp020 · Cited by 20
Fiorim, J., Júnior, R. F. R., Azevedo, B. F., Simões, M. R., Padilha, A. S., Stefanon, I., Alonso, M. J., Salaíces, M., & Vassallo, D. V. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.04.015 · Cited by 20
Marampon, F., Antinozzi, C., Corinaldesi, C., Vannelli, G. B., Sarchielli, E., Migliaccio, S., Luigi, L. D., Lenzi, A., & Crescioli, C. (2017) · Endocrine · doi:10.1007/s12020-017-1378-2 · Cited by 21
Controlling the Uptake and Regulating the Release of Nitric Oxide in Microporous Solids
Haikal, R. R., Hua, C., Perry, J. J., O’Nolan, D., Syed, I., Kumar, A., Chester, A. H., Zaworotko, M. J., Yacoub, M. H., & Alkordi, M. H. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b15095 · Cited by 20
Li, Y., & Liu, H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27362 · Cited by 20
“eNOS uncoupling has been implicated in a number of vascular diseases, such as hypertension and atherosclerosis, which are often accompanied by a reduction in BH4 levels.(6,7) BH4 is highly unstable and is easily oxidized; thus, it is not suitable for chronic oral administration.”
BackgroundEggebrecht, L., Prochaska, J. H., Schulz, A., Arnold, N., Jünger, C., Göbel, S., Laubert‐Reh, D., Binder, H., Beutel, M. E., Pfeiffer, N., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008650 · Cited by 20
“28 Endothelial BH4 depletion in turn may reduce vascular nitric oxide production or even cause endothelial nitric oxide synthase uncoupling associated with endothelial dysfunction and therefore higher vascular production of reactive oxygen species within the vascular wall.(29) Thus, the resulting reduction in vascular…”
BackgroundGenetic susceptibility to cerebrovascular disease: A systematic review
Griessenauer, C. J., Farrell, S., Sarkar, A., Zand, R., Abedi, V., Holland, N. R., Michael, A., Cummings, C. L., Metpally, R. P. R., Carey, D. J., et al. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18797958 · Cited by 21
“It encodes endothelial nitric oxide synthase, an enzyme on the vascular endothelium that produces nitric oxide, a substance that has various vaso-protective functions including inhibiting platelet aggregation and inducing vasodilation.(22) Wei et al.”
Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly
Ashley C, T., Mayank, A., & Nathan S, B. (2012) · Journal of Geriatric Cardiology · doi:10.3724/sp.j.1263.2011.00230 · Cited by 101
Metadata
- Authors
- Förstermann, U., & Münzel, T.
- Affiliations
- From the Departments of Pharmacology (U.F.) and Internal Medicine II (Cardiology) (T.M.), Johannes Gutenberg University Hospitals, Mainz, Germany.
- Venue
- Circulation
- Published
- 2006-04-04
- Volume
- 113
- Issue
- 13
- Pages
- 1708-1714
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2146190354
- Cited by
- 1,957
- References
- 67
- Citations by year
- 2026: 93 · 2025: 76 · 2024: 99 · 2023: 86 · 2022: 110 · 2021: 113 · 2020: 110 · 2019: 89 · 2018: 105 · 2017: 105 · 2016: 117 · 2015: 101 · 2014: 123 · 2013: 98 · 2012: 85
- FWCI
- 62.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- endothelial nitric oxide synthase, nitric oxide, tetrahydrobiopterin, eNOS uncoupling, NADPH oxidase, reactive oxygen species, superoxide, peroxynitrite, oxidative stress, cardiovascular risk factors, hypertension, hypercholesterolemia, diabetes mellitus, smoking, folic acid, vitamin C, L-arginine
- MeSH terms
- Animals, Endothelium, Vascular, Humans, Nitric Oxide, Vascular Diseases, Reactive Oxygen Species, Oxidative Stress, Nitric Oxide Synthase Type III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review